» Articles » PMID: 22503554

NOX5 Expression is Increased in Intramyocardial Blood Vessels and Cardiomyocytes After Acute Myocardial Infarction in Humans

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2012 Apr 17
PMID 22503554
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species producing NADPH oxidases play important roles under different (patho)physiological conditions. NOX1, NOX2, and NOX4 are important sources of reactive oxygen species in the heart, but knowledge of the calcium-dependent NOX5 in the heart is lacking. The presence of NOX5 was studied via RT-PCR in heart tissue from patients with end-stage heart failure; the tissue was obtained during cardiac transplantation surgery. NOX5 positivity and cellular localization were studied via IHC and digital-imaging microscopy in heart tissues of patients who did not have heart disease and in infarction areas of patients who died of myocardial infarctions of different durations. Furthermore, NOX5 expression was analyzed in vitro by using Western blot analysis. NOX5 RNA was found in the hearts of controls and patients with ischemic cardiomyopathy. In controls, NOX5 localized to the endothelium of a limited number of intramyocardial blood vessels and to a limited number of scattered cardiomyocytes. In infarcted hearts, NOX5 expression increased, especially in infarctions >12 hours, which manifested as an increase in NOX5-positive intramyocardial blood vessels, as well as in endothelium, smooth muscle, and cardiomyocytes. NOX5 was found in cardiomyocyte cytoplasm, plasma membrane, intercalated disks, and cross striations. Western blot analysis confirmed NOX5 expression in isolated human cardiomyocytes. For the first time to our knowledge, we demonstrate NOX5 expression in human intramyocardial blood vessels and cardiomyocytes, with significant increases in the affected myocardium after acute myocardial infarction.

Citing Articles

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases.

Jie H, Zhang J, Wu S, Yu L, Li S, Dong B Front Pharmacol. 2025; 15:1503824.

PMID: 39867658 PMC: 11757639. DOI: 10.3389/fphar.2024.1503824.


The functions of immune system-derived miRNAs in cardiovascular diseases.

Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T Noncoding RNA Res. 2024; 11:91-103.

PMID: 39736852 PMC: 11683256. DOI: 10.1016/j.ncrna.2024.11.004.


To activate NAD(P)H oxidase with a brief pulse of photodynamic action.

Xie X, Shu Y, Cui Z FASEB J. 2024; 38(23):e70246.

PMID: 39655710 PMC: 11629461. DOI: 10.1096/fj.202402292R.


Structural basis of human NOX5 activation.

Cui C, Jiang M, Jain N, Das S, Lo Y, Kermani A Nat Commun. 2024; 15(1):3994.

PMID: 38734761 PMC: 11088703. DOI: 10.1038/s41467-024-48467-y.


NADPH Oxidase 3: Beyond the Inner Ear.

Herb M Antioxidants (Basel). 2024; 13(2).

PMID: 38397817 PMC: 10886416. DOI: 10.3390/antiox13020219.